NOT-AI-10-035: Extension of Expiration Date and Additional Receipt Dates for RFA-AI-10-014: Ancillary Studies in Immunomodulation Clinical Trials (R01)

Extension of Expiration Date and Additional Receipt Dates for RFA AI-10-014: Ancillary Studies in Immunomodulation Clinical Trials (R01)

Notice Number: NOT-AI-10-035

Key Dates
Release Date: June 28, 2010
Opening Date: Thirty days prior to Letter of intent Date.
Letters of Intent Receipt Date(s): Thirty days prior to application receipt date
Application Due Date(s): September 9, 2010; December 9, 2010, and March 9, 2011
Peer Review Date(s): approximately twelve weeks after receipt date
Council Review Date(s): Special Electronic Council
Earliest Anticipated Start Date(s): approximately 17 weeks after receipt
Expiration Date: March 10, 2011

Issued by
National Institute of Allergy and Infectious Diseases (NIAID) (http://www.niaid.nih.gov)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (http://www.niams.nih.gov)
National Institute of Neurological Disorders and Stroke (NINDS) (http://www.ninds.nih.gov)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (http://www2.niddk.nih.gov)

Purpose

The purpose of this notice is to extend the expiration date of RFA-AI-10-014 Ancillary Studies in Immunomodulation Clinical Trials (R01) to March 10, 2011, and to add the following additional receipt dates: September 9, 2010; December 9, 2010; and March 9, 2011.

The participating NIH Institutes intend to commit approximately $2M in FY2011 to fund 4-5 new grants to support ancillary immune mechanistic studies in conjunction with independently supported clinical trials of immunomodulatory interventions for immune system mediated diseases or vaccine clinical trials for non-HIV/AIDS infectious diseases. Other than the changes noted above, other aspects of RFA-AI-10-014 remain unchanged.

Inquiries

We encourage your inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants. Inquiries may fall into three areas: scientific/research (program), peer review, and financial or grants management issues. Interested parties may contact:

1. Scientific/Research Contact(s):

Annette L. Rothermel, Ph.D.
Division of Allergy, Immunology and Transplantation
National Institute of Allergy and Infectious Diseases
Room 3020, MSC-6601
6610 Rockledge Drive
Bethesda, MD 20892- 6601
Telephone: 301-496-7104
Fax: 301-480-1450
Email: [email protected]

Yan Wang, M.D., Ph.D.
Division of Skin and Rheumatic Diseases, Extramural Program
National Institute of Arthritis and Musculoskeletal and Skin Diseases
One Democracy Plaza, Suite 800, MSC-4872
6701 Democracy Boulevard
Bethesda, MD 20892-4872
Phone: 301-594-5032
Fax: 301-480-1284
Email: [email protected]

Ursula Utz, Ph.D.
Neural Environment Program
National Institute of Neurological Disorders and Stroke
Room 213, MSC-9521
6001 Executive Boulevard
Bethesda, MD 20892-9521
Phone: 301-496-1431
FAX: 301-402-1501Email: [email protected]

Beena Akolkar, Ph.D.
Division of Diabetes, Endocrinology, and Metabolic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
Room 681, MSC-5460
6707 Democracy Boulevard
Bethesda, MD 20892-5460
Phone: 301-594-8812
FAX: 301-480-3503
Email: [email protected]

2. Peer Review Contact(s):

Paul Amstad, Ph.D.
Division of Extramural Activities
National Institute of Allergy and Infectious Diseases
Room 3121, MSC-7616
6700B Rockledge Drive
Bethesda, MD 20892-7616
Bethesda, MD 20817 (for express mail)
Telephone: 301-402-7098
Fax: 301-480-2408
Email: [email protected]

3. Financial/Grants Management Contact(s):

Victoria P. Connors
Division of Extramural Activities
National Institute of Allergy and Infectious Diseases
Room 2122, MSC-7614
6700 B Rockledge Drive
Bethesda, MD 20892-7614
Phone: (301) 402-5065
Fax: (301) 493-0597
Email: [email protected]